Evidence map›Paper›PMID 40583054›Full record

ArticleJournal of human genetics2025

Pseudoexon activating by a deep intronic variant and phenotype variation in a Chinese family with dystrophinopathy.

Xingyu Xia, Kexin Jiao, Chaoping Hu, Nachuan Cheng, Mingshi Gao, Shiyi Xiong, Ningning Wang, Bochen Zhu, Meining Diao, Dongyue Yue and 4 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xingyu Xia *Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Kexin Jiao *Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Chaoping HuDepartment of Neurology, Children's Hospital of Fudan University, Shanghai, China; National Children's Medical Center, Shanghai, China.
Nachuan ChengDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Mingshi GaoHuashan Rare Disease Center, Shanghai Medical College, Huashan Hospital, Fudan University, Shanghai, China.
Shiyi XiongShanghai Key Laboratory of Maternal Fetal Medicine, Department of Fetal Medicine and Prenatal Diagnosis Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Ningning WangDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Bochen ZhuDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Meining DiaoDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Dongyue YueDepartment of Neurology, Jing'an District Center Hospital of Shanghai, Shanghai, China.
Jianying XiDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Chongbo ZhaoDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Chengwen ChenShanghai Amplicongene Co. Ltd, Shanghai, China.
Wenhua ZhuDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China. whzhu@fudan.edu.cn.ORCID http://orcid.org/0000-0001-8011-0274

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82171398
6 · The paper itself

Abstract

Aberrant inclusion of pseudoexons (PE) in mature mRNA is a rare splicing defect contributing to Duchenne muscular dystrophy (DMD) pathogenesis. In this study, we described two affected males from a Chinese family who presented with progressive muscle weakness, elevated creatine kinase (CK) levels, and dystrophic changes on muscle pathology. Whole-genome sequencing followed by linkage-based filtering identified a shared deep intronic variant in intron 47 of DMD gene (c.6913-4037T>G), which activated a cryptic splice site and resulted in the inclusion of a 72 bp PE between exons 47 and 48. Patient induced pluripotent stem cells (iPSCs)-derived myotubes from the patient confirmed the presence of this PE, with a significant reduction in dystrophin expression compared to controls. Quantitative PCR revealed that aberrant transcripts comprised ~89% of total DMD transcripts in myotubes and ~97% in muscle, correlating with near-complete loss of dystrophin. Functional assays further showed impaired myotube fusion and altered calcium signaling. This study underscores the diagnostic complexity of intronic DMD variants and provides evidence supporting the pathogenicity of c.6913-4037T>G.

Indexed as

DystrophinExonsIntronsMuscular Dystrophy, DuchenneAdolescentChild, PreschoolChinaEast Asian PeopleFemaleHumansInduced Pluripotent Stem CellsMaleMuscle Fibers, SkeletalMuscle, SkeletalPedigreePhenotypeDMD protein, humanDystrophin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.